Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?

被引:110
作者
Baur, A
Stäbler, A
Nagel, D
Lamerz, R
Bartl, R
Hiller, E
Wendtner, C
Bachner, F
Reiser, M
机构
[1] Univ Munich, Klinikum Grosshadern, Dept Clin Radiol, D-81377 Munich, Germany
[2] Univ Munich, Klinikum Grosshadern, Dept Clin Chem, D-81377 Munich, Germany
[3] Univ Munich, Klinikum Grosshadern, Dept Internal Med 2, D-81377 Munich, Germany
关键词
multiple myeloma; MRI; prognosis; staging system; spine; bone marrow; survival;
D O I
10.1002/cncr.10818
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. This study evaluated the prognostic value of a three-grade staging system of spinal involvement using magnetic resonance imaging (MRI) in patients with multiple myeloma and determined its usefulness as an independent parameter in the staging system of Durie and Salmon. METHODS. Seventy-seven previously untreated patients with multiple myeloma underwent MRI of the thoracic and lumbar spine with unenhanced T1-weighted spin echo and short-tau inversion time inversion recovery sequences. The patients were evaluated according to their infiltration patterns and the extent of bone marrow involvement was staged using a three-grade scale: Stage 1, no focal or diffuse infiltration; Stage II, 1-10 foci or mild diffuse infiltration; Stage III, more than 10 foci or strong diffuse infiltration. RESULTS. The infiltration patterns had no significant effect on survival. Of 77 patients, 25 would have been understaged using the standard staging system of Durie and Salmon without the findings of MRI and 8 patients would have been understaged if the staging was based only on MRI. The combination of the staging system of Durie and Salmon and MRI was highly significant with respect to survival (P < 0.0001, log rank analysis). MRI staging I-III was independent of the staging system of Durie and Salmon (Cox regression model). CONCLUSIONS. A three-grade staging of spinal MRI provides a significant prognostic tool for patients with multiple myeloma. The authors propose including it in the staging system of Durie and Salmon. (C) 2002 American Cancer Society.
引用
收藏
页码:1334 / 1345
页数:12
相关论文
共 43 条
[21]  
GREIPP PR, 1993, BLOOD, V81, P3382
[22]   PROGNOSIS IN MYELOMA [J].
GREIPP, PR .
MAYO CLINIC PROCEEDINGS, 1994, 69 (09) :895-902
[23]   Bisphosphonates in multiple myeloma: Current status; Future perspectives [J].
Juntunen, E ;
Laakso, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (03) :501-506
[24]  
KANIS JA, 1986, MULTIPLE MYELOMA OTH, P307
[25]   Magnetic resonance imaging patterns in patients with multiple myeloma [J].
Kusumoto, S ;
Jinnai, I ;
Itoh, K ;
Kawai, N ;
Sakata, T ;
Matsuda, A ;
Tominaga, K ;
Murohashi, I ;
Bessho, M ;
Harashima, K ;
Heshiki, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (03) :649-655
[26]   Diagnostic challenges and standard therapy [J].
Kyle, RA .
SEMINARS IN HEMATOLOGY, 2001, 38 (02) :11-14
[27]   The role of bisphosphonates in multiple myeloma [J].
Kyle, RA .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (09) :734-736
[28]   LONG-TERM SURVIVAL IN MULTIPLE-MYELOMA [J].
KYLE, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (06) :314-316
[29]   Stage III multiple myeloma: Clinical and prognostic value of spinal bone marrow MR imaging [J].
Lecouvet, FE ;
Vande Berg, BC ;
Michaux, L ;
Malghem, J ;
Maldague, BE ;
Jamart, J ;
Ferrant, A ;
Michaux, JL .
RADIOLOGY, 1998, 209 (03) :653-660
[30]   Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey [J].
Lecouvet, FE ;
Malghem, J ;
Michaux, L ;
Maldague, B ;
Ferrant, A ;
Michaux, JL ;
Berg, BCV .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (01) :35-39